- Home
- FLGT vs AVK Comparison
FLGT vs AVK Comparison
Compare FLGT & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- AVK
- Stock Information
- Founded
- FLGT 2011
- AVK 2003
- Country
- FLGT United States
- AVK United States
- Employees
- FLGT N/A
- AVK N/A
- Industry
- FLGT Medical Specialities
- AVK Trusts Except Educational Religious and Charitable
- Sector
- FLGT Health Care
- AVK Finance
- Exchange
- FLGT Nasdaq
- AVK Nasdaq
- Market Cap
- FLGT 508.7M
- AVK 424.5M
- IPO Year
- FLGT 2016
- AVK N/A
- Fundamental
- Price
- FLGT $16.46
- AVK $12.08
- Analyst Decision
- FLGT Hold
- AVK
- Analyst Count
- FLGT 1
- AVK 0
- Target Price
- FLGT $22.00
- AVK N/A
- AVG Volume (30 Days)
- FLGT 225.7K
- AVK 112.9K
- Earning Date
- FLGT 02-28-2025
- AVK 01-01-0001
- Dividend Yield
- FLGT N/A
- AVK 11.85%
- EPS Growth
- FLGT N/A
- AVK N/A
- EPS
- FLGT N/A
- AVK N/A
- Revenue
- FLGT $277,761,000.00
- AVK N/A
- Revenue This Year
- FLGT N/A
- AVK N/A
- Revenue Next Year
- FLGT $16.00
- AVK N/A
- P/E Ratio
- FLGT N/A
- AVK N/A
- Revenue Growth
- FLGT N/A
- AVK N/A
- 52 Week Low
- FLGT $15.99
- AVK $9.24
- 52 Week High
- FLGT $25.50
- AVK $12.16
- Technical
- Relative Strength Index (RSI)
- FLGT 42.71
- AVK 42.85
- Support Level
- FLGT $16.47
- AVK $12.21
- Resistance Level
- FLGT $17.39
- AVK $12.34
- Average True Range (ATR)
- FLGT 0.54
- AVK 0.12
- MACD
- FLGT 0.10
- AVK -0.03
- Stochastic Oscillator
- FLGT 33.57
- AVK 15.00
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About AVK Advent Convertible and Income Fund
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.